|
Volumn 74, Issue 10, 2003, Pages 1154-1159
|
Effectiveness of passive immunisation against respiratory syncytium virus in a group of premature infants with birth weight below 1000 grams;Ocena skuteczności stosowania uodpornienia biernego przeciwko wirusom syncytium nabłonka oddechowego (RSV) preparatem Synagis w grupie wcześniakow z masa urodzeniowa ciała ponizej 1000 gramow.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
MONOCLONAL ANTIBODY;
PALIVIZUMAB;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG EFFECT;
FEMALE;
HUMAN;
IMMUNOLOGY;
INFANT;
MALE;
METHODOLOGY;
NEWBORN;
NEWBORN INTENSIVE CARE;
PASSIVE IMMUNIZATION;
PREMATURITY;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
RISK FACTOR;
TIME;
TREATMENT OUTCOME;
UTILIZATION REVIEW;
VERY LOW BIRTH WEIGHT;
VIROLOGY;
VIRUS INFECTION;
ANTIBODIES, MONOCLONAL;
ANTIVIRAL AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
IMMUNIZATION, PASSIVE;
INFANT;
INFANT, NEWBORN;
INFANT, PREMATURE, DISEASES;
INFANT, VERY LOW BIRTH WEIGHT;
INTENSIVE CARE UNITS, NEONATAL;
MALE;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
RESPIRATORY SYNCYTIAL VIRUSES;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 1542393026
PISSN: 00170011
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|